The Effect of Virtual Reality-based Training Program on Improving Upper-Limb Functions in Participants With Stroke.
NCT ID: NCT04764994
Last Updated: 2022-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2021-02-18
2021-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Upper Extremity Training for Improving Balance Control Post-Stroke
NCT05049018
The Development of Upper Extremity Rehabilitation Program Using Virtual Reality for the Stroke Patients
NCT02013999
Modulation of Upper Limb Spasticity Post-Stroke
NCT05069480
Upper Arm Training With Armeo Spring for Stroke
NCT01485354
Efficacy of Virtual Reality in Upper Extremity Rehabilitation for Stroke Patients
NCT06143176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are 5 phases for this research work: (1) preparation phase, (2) Therapeutic intervention phase, (3) Evaluation phase, (4) Phase of data and statistical analyses, (5) The phase of Result Publication Phase.
Phase (1): Preparation phase.
This phase have been undertaken to set up and identify the inclusion and exclusion criteria of participant patients, determination of the sample size and randomization procedure for this study, purchasing the instruments that will be used in the study.
1.1 Setting up participant criteria. (This phase has completed) 1.2 Determination of the sample size and randomization procedure. Sample size: 40 patients will participated in this study. They will divided randomly to equal groups.
Randomization: (Not yet recruiting) In order to eliminate bias in treatment, randomization will be established for the patients who will be included in both experimental group A \& control group B. It permits the use of probability theory to express the likelihood that any difference in outcome between treatment groups merely indicates chance. Evaluation of the patients with stroke will be performed by evaluators who will not participated in application of intervention and the therapists will be blinded from the randomization and blinding process. Simple randomization using a randomization table created by computer software (i.e. computerized sequence generation)
1.3 Purchasing the instruments. (This phase has completed) The following device has been already purchased: Armeo Functional upper extremity rehabilitation (MRF; Hocoma, Switzerland). (For treatment)
* Other evaluation instruments that will be used in this study are available in the University Research Labs
Phase (2): Therapeutic intervention phase. (This phase has not yet started)
Therapeutic intervention will be carried out three sessions per week for twelve successive weeks for both experimental and control groups. The treatment session will continue 2 hours with 15 minute rest between the first and the second hours. (More details are explained in the intervention section)
Phase (3): Evaluation phase. (This phase has not yet started)
The evaluation phase include the examination of the study predetermined parameters at both baseline, and 12 weeks after intervention commencement
Phase (4): Data and Statistical Analysis phase. This phase will start after all participants who will recruited for this study will be examined for the purposes of final collection of out-come data.
The statistical analysis will include:
The differences in demographics (such as age, height and weight) between study/experimental and control groups before treatment will be examined using one-way ANOVA.
Paired t test will be used to identify the mean differences in outcome measures within groups to compare the means of primary and secondary outcome measures between pre-treatment and post-treatment for each group.
One-way ANOVA with post-hoc tests will be used to identify the mean differences in primary and secondary outcome measures between study/experimental and control groups.
Phase (5): Result Publication Phase. This phase will start after all participants who will recruited for this study will be examined for the purposes of final collection of out-come data
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Participants who will participated in the control group will receive a conventional physical therapy program for two hours. It will include two parts, each of them will be one hour and 15 minutes rest in between. The first part will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises. The second part will include: arm-reaching tasks, arm-hand tasks, manipulative tasks (grasping and release activities) and upper limb self-dependent tasks and the inclusion of the more affected upper limb in functional tasks of daily living activities.
The conventional treatment program will be applied for both groups by therapists, experienced in stroke rehabilitation.
Treatment frequency (Dose): Therapeutic intervention will be carried out three sessions per week for twelve successive weeks.
Conventional Physical Therapy Program
This intervention t will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises.
Study Group
Participants of study group will receive two hours treatment program that will include three parts, the first and the second parts (similar to that will be applied for participants in control group) will be together for one hour following by 15 minutes rest, then the third part will apply for one hour. The third part of the program will be one hour virtual reality intervention program by using Armeo Spring to simulate a range of upper limb tasks related to arm-reaching to target, reach and grasp (arm-hand activities) and manipulative tasks through using different games and soft-wares.
The conventional treatment part of the program will be applied by therapists, experienced in stroke rehabilitation. The virtual reality part of the program will be applied by another experienced physiotherapists, who are well trained in using Armeo Spring System.
Treatment frequency (Dose): Therapeutic intervention will be carried out three sessions per week for twelve successive weeks.
Armeo®Spring ((Task-oriented upper extremity rehabilitation system)
Armeo®Spring is a functional upper extremity rehabilitation device to provide specific therapy with augmented feedback. The Armeo Spring instrument facilitates intensive task-oriented upper extremity therapy after stroke, traumatic brain injury or other neurological diseases and injuries. It combines an adjustable arm support, with augmented feedback and a large 3D workspace that allows functional therapy exercises in a virtual reality environment.
Conventional Physical Therapy Program
This intervention t will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Armeo®Spring ((Task-oriented upper extremity rehabilitation system)
Armeo®Spring is a functional upper extremity rehabilitation device to provide specific therapy with augmented feedback. The Armeo Spring instrument facilitates intensive task-oriented upper extremity therapy after stroke, traumatic brain injury or other neurological diseases and injuries. It combines an adjustable arm support, with augmented feedback and a large 3D workspace that allows functional therapy exercises in a virtual reality environment.
Conventional Physical Therapy Program
This intervention t will include: muscle facilitation exercises, proprioceptive neuromuscular facilitation exercises, strengthening activities, stretching exercises and postural reactions exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participating participants will have a confirmed diagnosis of stroke confirmed by magnetic resonance images (MRIs) obtained from medical records or personal physicians.
* They should be medically stable and will have neither serious nor recurring medical complications according to the medical report signed by their physician.
* The age of participants will be between 50 to 60 years.
* Participants of both genders will be recruited
* The participants will be selected to be in spastic phase, 6-24 months following a first stroke.
* The degree of spasticity in upper extremity according to Modified Ashworth Scale will ranged between grades 1,1+\&2.
* The included participants should be cognitively competent and able to understand and follow instructions.
* The participants will associated with neither fixed stiffness in shoulder, elbow, wrist and fingers joints nor major rotational mal-alignments in the upper limbs.
* The patient should have the ability to extend the wrist at least 20° and fingers 10° from full flexion. This range will allow participants to engage easily in performing a designed program.
* Also they should have no serious problems affecting balance performance other than spasticity due to stroke.
* During the study, participants will not receive any treatment to improve involved upper limb functions other than the study intervention.
Exclusion Criteria
* Cognitive decline (Mini-Mental State Examination \< 23 points). Due to the requirements of the ARMEO system.
* Shoulder pain on a visual analogue scale of \> 6/10.
* Spasticity score ≥ 2 according to the Modified Ashworth Scale
* Conditions affecting their participations in this study (e.g. cardiac, respiratory, seizures or arthritic problems)
* Visual problems that may prevent them from performing the intervention
* Botulinum toxin in the upper extremity musculature six months before baseline assessment or who wished to receive it within the period of study,
* Muscle-tone control medications before baseline assessment or who wished to receive it within the period of study.
* A cardiac pacemaker as the electromagnetic motion tracker used within the virtual reality system might interfere with such devices.
50 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umm Al-Qura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ehab Mohamed Abd El Kafy
Professor of Physical Therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ehab Abd El Kafy, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Professor of Physical Therapy -Umm Al Qura University.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ehab Abd El Kafy
Mecca, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-MED998-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.